Literature DB >> 28226228

Antigen-Presenting Cells in the Skin.

Sakeen W Kashem1, Muzlifah Haniffa2,3, Daniel H Kaplan4,5.   

Abstract

Professional antigen-presenting cells (APCs) in the skin include dendritic cells, monocytes, and macrophages. They are highly dynamic, with the capacity to enter skin from the peripheral circulation, patrol within tissue, and migrate through lymphatics to draining lymph nodes. Skin APCs are endowed with antigen-sensing, -processing, and -presenting machinery and play key roles in initiating, modulating, and resolving cutaneous inflammation. Skin APCs are a highly heterogeneous population with functionally specialized subsets that are developmentally imprinted and modulated by local tissue microenvironmental and inflammatory cues. This review explores recent advances that have allowed for a more accurate taxonomy of APC subsets found in both mouse and human skin. It also examines the functional specificity of individual APC subsets and their collaboration with other immune cell types that together promote adaptive T cell and regional cutaneous immune responses during homeostasis, inflammation, and disease.

Entities:  

Keywords:  Langerhans cells; antigen-presenting cells; cutaneous immunology; dendritic cells; macrophages; skin

Mesh:

Year:  2017        PMID: 28226228     DOI: 10.1146/annurev-immunol-051116-052215

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  90 in total

1.  DRM02, a novel phosphodiesterase-4 inhibitor with cutaneous anti-inflammatory activity.

Authors:  David W C Hunt; Iordanka A Ivanova; Lina Dagnino
Journal:  Tissue Barriers       Date:  2020-06-01

2.  Cutaneous TRPV1+ Neurons Trigger Protective Innate Type 17 Anticipatory Immunity.

Authors:  Jonathan A Cohen; Tara N Edwards; Andrew W Liu; Toshiro Hirai; Marsha Ritter Jones; Jianing Wu; Yao Li; Shiqun Zhang; Jonhan Ho; Brian M Davis; Kathryn M Albers; Daniel H Kaplan
Journal:  Cell       Date:  2019-07-25       Impact factor: 41.582

3.  Influences of nanocarrier morphology on therapeutic immunomodulation.

Authors:  Molly Frey; Sharan Bobbala; Nicholas Karabin; Evan Scott
Journal:  Nanomedicine (Lond)       Date:  2018-08-07       Impact factor: 5.307

4.  A protective Langerhans cell-keratinocyte axis that is dysfunctional in photosensitivity.

Authors:  William D Shipman; Susan Chyou; Anusha Ramanathan; Peter M Izmirly; Sneh Sharma; Tania Pannellini; Dragos C Dasoveanu; Xiaoping Qing; Cynthia M Magro; Richard D Granstein; Michelle A Lowes; Eric G Pamer; Daniel H Kaplan; Jane E Salmon; Babak J Mehrara; James W Young; Robert M Clancy; Carl P Blobel; Theresa T Lu
Journal:  Sci Transl Med       Date:  2018-08-15       Impact factor: 17.956

Review 5.  Skin and respiratory chemical allergy: confluence and divergence in a hybrid adverse outcome pathway.

Authors:  Ian Kimber; Alan Poole; David A Basketter
Journal:  Toxicol Res (Camb)       Date:  2018-01-26       Impact factor: 3.524

6.  A transcriptomic map of murine and human alopecia areata.

Authors:  Nicholas Borcherding; Sydney B Crotts; Luana S Ortolan; Nicholas Henderson; Nicholas L Bormann; Ali Jabbari
Journal:  JCI Insight       Date:  2020-07-09

7.  Formulation and Delivery Technologies for mRNA Vaccines.

Authors:  Chunxi Zeng; Chengxiang Zhang; Patrick G Walker; Yizhou Dong
Journal:  Curr Top Microbiol Immunol       Date:  2020-06-02       Impact factor: 4.291

Review 8.  Ontogeny and function of murine epidermal Langerhans cells.

Authors:  Daniel H Kaplan
Journal:  Nat Immunol       Date:  2017-09-19       Impact factor: 25.606

9.  Human Three-Dimensional Models for Studying Skin Pathogens.

Authors:  Elena Boero; Malgorzata Ewa Mnich; Andrea Guido Oreste Manetti; Elisabetta Soldaini; Luca Grimaldi; Fabio Bagnoli
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

Review 10.  The potential role of using vaccine patches to induce immunity: platform and pathways to innovation and commercialization.

Authors:  Kamran Badizadegan; James L Goodson; Paul A Rota; Kimberly M Thompson
Journal:  Expert Rev Vaccines       Date:  2020-03-17       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.